E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8
- PMID: 18794899
- PMCID: PMC3148807
- DOI: 10.1038/nature07310
E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8
Abstract
The E2F1 transcription factor can promote proliferation or apoptosis when activated, and is a key downstream target of the retinoblastoma tumour suppressor protein (pRB). Here we show that E2F1 is a potent and specific inhibitor of beta-catenin/T-cell factor (TCF)-dependent transcription, and that this function contributes to E2F1-induced apoptosis. E2F1 deregulation suppresses beta-catenin activity in an adenomatous polyposis coli (APC)/glycogen synthase kinase-3 (GSK3)-independent manner, reducing the expression of key beta-catenin targets including c-MYC. This interaction explains why colorectal tumours, which depend on beta-catenin transcription for their abnormal proliferation, keep RB1 intact. Remarkably, E2F1 activity is also repressed by cyclin-dependent kinase-8 (CDK8), a colorectal oncoprotein. Elevated levels of CDK8 protect beta-catenin/TCF-dependent transcription from inhibition by E2F1. Thus, by retaining RB1 and amplifying CDK8, colorectal tumour cells select conditions that collectively suppress E2F1 and enhance the activity of beta-catenin.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3148807/bin/nihms96496f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3148807/bin/nihms96496f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3148807/bin/nihms96496f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3148807/bin/nihms96496f4.gif)
Comment in
-
Cancer: Entangled pathways.Nature. 2008 Sep 25;455(7212):479-80. doi: 10.1038/455479a. Nature. 2008. PMID: 18818647 No abstract available.
Similar articles
-
Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.Carcinogenesis. 2013 Feb;34(2):277-86. doi: 10.1093/carcin/bgs351. Epub 2012 Nov 5. Carcinogenesis. 2013. PMID: 23129580
-
Cancer: Entangled pathways.Nature. 2008 Sep 25;455(7212):479-80. doi: 10.1038/455479a. Nature. 2008. PMID: 18818647 No abstract available.
-
CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation.Oncogene. 2013 Jul 25;32(30):3520-30. doi: 10.1038/onc.2012.364. Epub 2012 Sep 3. Oncogene. 2013. PMID: 22945643
-
Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells.Toxicology. 2013 Oct 4;312:36-47. doi: 10.1016/j.tox.2013.07.013. Epub 2013 Jul 30. Toxicology. 2013. PMID: 23907061 Review.
-
Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.Cells. 2020 Sep 19;9(9):2125. doi: 10.3390/cells9092125. Cells. 2020. PMID: 32961708 Free PMC article. Review.
Cited by
-
Wnt signaling modulates the response to DNA damage in the Drosophila wing imaginal disc by regulating the EGFR pathway.PLoS Biol. 2024 Jul 24;22(7):e3002547. doi: 10.1371/journal.pbio.3002547. eCollection 2024 Jul. PLoS Biol. 2024. PMID: 39047051 Free PMC article.
-
PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways.Exp Mol Med. 2024 Jul;56(7):1479-1487. doi: 10.1038/s12276-024-01260-9. Epub 2024 Jul 1. Exp Mol Med. 2024. PMID: 38945955 Free PMC article. Review.
-
Human pan-cancer analysis of the predictive biomarker for the CDKN3.Eur J Med Res. 2024 May 8;29(1):272. doi: 10.1186/s40001-024-01869-6. Eur J Med Res. 2024. PMID: 38720365 Free PMC article.
-
Mediator kinase module proteins, genetic alterations and expression of super-enhancer regulated genes in colorectal cancer.Pharmacol Rep. 2024 Jun;76(3):535-556. doi: 10.1007/s43440-024-00589-2. Epub 2024 Apr 11. Pharmacol Rep. 2024. PMID: 38602606
-
MED12 mutation activates the tryptophan/kynurenine/AHR pathway to promote growth of uterine leiomyomas.JCI Insight. 2023 Sep 22;8(18):e171305. doi: 10.1172/jci.insight.171305. JCI Insight. 2023. PMID: 37607000 Free PMC article.
References
-
- Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda M, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs C, Loda M, Shivdasani RA, Meyerson M, Hahn WC. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. 2008 - PMC - PubMed
-
- Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127:469–480. - PubMed
-
- Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159–170. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 GM071449/GM/NIGMS NIH HHS/United States
- R01 GM053203/GM/NIGMS NIH HHS/United States
- GM81607/GM/NIGMS NIH HHS/United States
- R01 GM071449-04/GM/NIGMS NIH HHS/United States
- R01 GM081607-01A1/GM/NIGMS NIH HHS/United States
- R01 GM053203-13/GM/NIGMS NIH HHS/United States
- GM071449/GM/NIGMS NIH HHS/United States
- P50 CA127003-02/CA/NCI NIH HHS/United States
- R01 GM053203-14/GM/NIGMS NIH HHS/United States
- R01 GM081607/GM/NIGMS NIH HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
- GM053203/GM/NIGMS NIH HHS/United States
- P50-CA127003/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous